Skip to main content

Banco Bradesco Expands Healthcare Partnership with Rede D’Or

Tipranks - Tipranks - Tue Nov 11, 2025

Meet Your ETF AI Analyst

An update from Banco Bradesco SA ( (BBD) ) is now available.

On November 10, 2025, Banco Bradesco S.A. announced that its indirectly controlled investment company, Atlântica Hospitais e Participações, S.A., signed an Investment Agreement with Rede D’Or São Luiz S.A. Group to include Maternidade São Luiz Star in the ‘Atlântica D’Or’ structure. This expansion, part of a partnership initially disclosed in May 2024, aligns with Atlântica’s strategy to invest in the healthcare value chain. The transaction, which maintains the current ownership structure, is pending regulatory approvals and is expected to enhance Bradesco’s positioning in the healthcare sector.

The most recent analyst rating on (BBD) stock is a Buy with a $3.50 price target. To see the full list of analyst forecasts on Banco Bradesco SA stock, see the BBD Stock Forecast page.

Spark’s Take on BBD Stock

According to Spark, TipRanks’ AI Analyst, BBD is a Outperform.

Banco Bradesco SA’s strong earnings growth and strategic initiatives in technology are the most significant factors contributing to its score. Positive technical indicators and reasonable valuation further support the stock’s outlook. However, liquidity concerns and high leverage present risks that need careful management.

To see Spark’s full report on BBD stock, click here.

More about Banco Bradesco SA

Banco Bradesco S.A. is a prominent financial institution in Brazil, primarily engaged in banking and financial services. It operates in various sectors, including retail banking, insurance, and investment services, focusing on expanding its presence in the healthcare industry through strategic partnerships.

Average Trading Volume: 46,488,044

Technical Sentiment Signal: Buy

Current Market Cap: $34.39B

For detailed information about BBD stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Trending Articles

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).